FREDERICK V PLAPP, MD PHD
Medical Practice at Wornall Rd, Kansas City, MO

License number
Missouri R2C75
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
License number
Missouri 0417332
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address 2
4401 Wornall Rd, Kansas City, MO 64111
12814 Woodson St, Overland Park, KS 66209
Phone
(816) 932-3335
(816) 932-3822 (Fax)
(913) 897-6974

Professional information

See more information about FREDERICK V PLAPP at trustoria.com
Frederick V Plapp Photo 1
Frederick V Plapp, Kansas City MO

Frederick V Plapp, Kansas City MO

Specialties:
Pathology, Clinical Pathology/Laboratory Medicine, Anatomic Pathology & Clinical Pathology, Clinical Pathology
Work:
St Lukes Hospital Of Kansas City
4401 Wornall Rd, Kansas City, MO 64111
Education:
University of Kansas(1975)


Frederick Plapp Photo 2
Solid Phase Indicator Red Blood Cells And Method

Solid Phase Indicator Red Blood Cells And Method

US Patent:
4816413, Mar 28, 1989
Filed:
Sep 8, 1986
Appl. No.:
6/904948
Inventors:
Lyle T. Sinor - Merriam KS
Frederick V. Plapp - Overland Park KS
Jane M. Rachel - Kansas City MO
Assignee:
Immucor, Inc. - Norcross GA
International Classification:
G01N 33555, G01N 33549
US Classification:
436520
Abstract:
A method and composition for use in preparing red blood cells for use as indicator cells to detect the presence of antigens and antibodies in biological fluids is the subject of the present invention. Freshly collected human or animal erythrocytes are washed six times with isotonic saline, and suspended to a hematocrit of four percent (volume/volume) with isotonic saline. An incomplete antibody, specific for the antigen or antibody to be detected, in a quantity less than that which would cause irreversible agglutination, is added to the erythrocyte solution. The mixture is incubated, washed, and suspended to a hematocrit of 3-5 (v/v) with isotonic saline. A second antibody, immuno specific for the first antibody and in an amount sufficiently great to immunologically bind substantially all of the antibody carrying red blood cells but not so great as to cause irreversible agglutination, is attached to the erythrocytes. This mixture is incubated, washed, and suspended to a hematocrit of 0. 1-1% (v/v) in a media containing red blood cell nutrients.


Frederick Plapp Photo 3
Vial Stopper Removal Device

Vial Stopper Removal Device

US Patent:
4841818, Jun 27, 1989
Filed:
Feb 1, 1988
Appl. No.:
7/150541
Inventors:
Christopher V. Plapp - Overland Park KS
Frederick A. Plapp - Mission KS
Frederick V. Plapp - Overland Park KS
International Classification:
B25B 2700
US Classification:
81 308
Abstract:
A device and method for removing closures from laboratory sample containers is the subject of the present invention. The device consists of a tubular member which is large enough to contain a laboratory sample container or vial. Integral with one end of the tubular member is a housing member which is large enough to contain the stopper or closure for the laboratory vial and is thus of a diameter larger than the tubular member. The end of the housing opposite the tubular member is closable with an irreversibly locking cap. A vial with a stopper to be removed is placed into the cap end of the housing member and is received by the tubular member unitl the stopper rests on the bottom surface of the housing member. The cap on the housing member is closed and a force is exerted on the vial to dislodge the stopper from it. The vial is pulled through the tubular member, leaving the stopper in the housing member.